EXCLOVIS Trademark

Trademark Overview

On Thursday, August 1, 2019, a trademark application was filed for EXCLOVIS with the United States Patent and Trademark Office. The USPTO has given the EXCLOVIS trademark a serial number of 88559688. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 13, 2023. This trademark is owned by Sarepta Therapeutics, Inc.. The EXCLOVIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders
exclovis

General Information

Serial Number88559688
Word MarkEXCLOVIS
Filing DateThursday, August 1, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 13, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 12, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neuromuscular diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 19, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSarepta Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameSarepta Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, February 13, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 13, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, July 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 7, 2022SOU EXTENSION 5 GRANTED
Thursday, June 23, 2022SOU EXTENSION 5 FILED
Thursday, July 7, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 23, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, January 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 3, 2022SOU EXTENSION 4 GRANTED
Monday, January 3, 2022SOU EXTENSION 4 FILED
Monday, January 3, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, June 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 11, 2021SOU EXTENSION 3 GRANTED
Friday, June 11, 2021SOU EXTENSION 3 FILED
Friday, June 11, 2021SOU TEAS EXTENSION RECEIVED
Saturday, December 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 10, 2020SOU EXTENSION 2 GRANTED
Thursday, December 10, 2020SOU EXTENSION 2 FILED
Thursday, December 10, 2020SOU TEAS EXTENSION RECEIVED
Saturday, June 20, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 18, 2020SOU EXTENSION 1 GRANTED
Thursday, June 18, 2020SOU EXTENSION 1 FILED
Thursday, June 18, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, January 7, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 12, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 23, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 4, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 30, 2019ASSIGNED TO EXAMINER
Monday, August 19, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 5, 2019NEW APPLICATION ENTERED

Related Keywords

exclovis diseases disorders neuromuscular treatment preparations pharmaceutical